Emerald Group Publishing Limited
Copyright © 2008, Emerald Group Publishing Limited
National Institutes of Health (NIH)
Article Type: Food facts From: Nutrition
Study Confirmed EPAX Formula Effective in Preventing Alzheimer's Patients' Memory Decline. The Omega-3 Alzheimer's Disease (OMEGAD) study that used an EPAX AS formula has been selected by The Office of Dietary Supplements (ODS) at the NIH as one of the 25 best scientific articles in 2006.
This study showed that memory decline could be halted in patients with early-stage Alzheimer's dementia when given EPAX 1050 TG. This marine, DHA-enriched omega-3 formula has a favourable concentration and special composition of EPA/DHA fatty acids in relation to cognition and brain-related functions. The OMEGAD study appears in the 2006 Annual Bibliography of Significant Advances in Dietary Supplement Research, published by the ODS and NIH, which highlights 25 of the most significant dietary supplement research advances of the past year.
For further information on EPAX AS, its products or clinical studies visit: www.epax.com